Fig. 5

Comparison of tenocyte proliferation in the xCELLigence system and conventional culture system upon exposure to ketorolac tromethamine, bupivacaine, methylprednisolone, and betamethasone at 100, 50, and 10% of their respective clinical doses. Tenocytes exposed to 100% of ketorolac tromethamine, bupivacaine, methylprednisolone, and betamethasone in the xCELLigence system (a) and conventional cell culture (b). Tenocytes exposed to 50% of ketorolac tromethamine, bupivacaine, methylprednisolone, and betamethasone in the xCELLigence system (c) and conventional cell culture (d). Tenocytes exposed to 10% of ketorolac tromethamine, bupivacaine, methylprednisolone, and betamethasone in the xCELLigence system (e) and conventional cell culture (f). * p < .05